Buenos Aires, Argentina—March 15, 2012—Heath experts from throughout the Americas will reveal new findings on the meningitis disease prevalence in Latin America and Caribbean (LAC), following a March 19-20, 2012 regional health meeting. Researchers will present the first-ever study to estimate the cost of meningococcal disease in selected countries in the region, as well costs associated with control of an outbreak. These new findings will call attention to the need for improved meningococcal vaccination programs throughout the region.
WHAT: A press conference detailing the results of a new study measuring the economic burden of meningitis in Latin America. The press conference will conclude a two-day symposium that brings together health leaders to review the meningococcal situation in the region and recommends new approaches to reduce and eliminate the disease burden in the Americas.
WHEN: March 20, 2012
12 p.m. AST *LUNCH WILL BE SERVED
WHERE: Marriott Plaza Hotel, 1st Floor Plaza
Florida 1005, at the San Martin Plaza
El Retiro, Buenos Aires
WHO: The 1st Regional Meningococcal Symposium is convened by:
The Sabin Vaccine Institute
Pan American Health Organization (PAHO), Regional Office of the World Health Organization
WHY: Meningococcal meningitis, which infects the membranes of the brain and spinal cord, is a debilitating and potentially fatal disease for children, adolescents and people living in overcrowded housing. Researchers, vaccinologists, economists and others are evaluating its extent, cost and obstacles to prevention through vaccination. With several vaccines available for different types of meningitis, experts will discuss current and upcoming vaccines and new strategies to prevent the disease. The study being presented was coordinated by the Sabin Vaccine Institute in partnership with the Pan-American Health Organization (PAHO), the International Vaccine Access Center at Johns Hopkins University (JHU’s IVAC) and the Centers for Diseases Control and Prevention (CDC).
For more information, contact:
Johanna Harvey, Communications Officer, Sabin Vaccine Institute, Johanna.Harvey@Sabin.org, Tel: +1 (202) 621-1691 Mobile: +1 (336) 202-0324
Daniel Epstein, Communications Consultant, Sabin Vaccine Institute, email@example.com, Tel: +1 (301) 219-2105